Skeletal muscle and mortality results from the InCHIANTI Study
- PMID: 19181709
- PMCID: PMC2655006
- DOI: 10.1093/gerona/gln031
Skeletal muscle and mortality results from the InCHIANTI Study
Abstract
Background: Sarcopenia, the age-related loss of muscle mass, may not be an isolated process but is associated with an increase in fat mass. The aim of this study was to estimate the mortality risk of sarcopenia in the presence or absence of obesity.
Methods: Data are from 934 participants aged 65 years or older, enrolled in the "Invecchiare in Chianti" study, and followed for 6 years. At baseline, a peripheral quantitative computerized tomography (pQCT) scan was performed on all participants to evaluate the muscle density, and the muscular and fat cross-sectional areas of the calf. Walking speed was measured on a 7-m track. Cox proportional hazard models were performed to estimate the association of pQCT measures (per 1 standard deviation increase) with mortality.
Results: Unadjusted analyses showed significant associations of muscle density (hazard ratio [HR] 0.78, 95% confidence interval [CI] 0.69-0.88), muscle area (HR 0.75, 95% CI 0.66-0.86), and fat area (HR 0.82, 95% CI 0.73-0.92) with mortality. After adjustment for potential confounders, no body composition parameter was significantly associated with mortality. Walking speed (used as a reference measure to verify whether the negative results were due to peculiarities of the study sample) confirmed its well-established association with mortality risk (HR 0.73, 95% CI 0.60-0.88). These results did not change after the analyses were stratified according to sarcopenia and body mass index groups, and restricted to participants with frailty or a high inflammatory profile.
Conclusions: Calf skeletal muscle and fat mass are not significant risk factors for mortality in community-dwelling older adults. Walking speed confirmed to be a powerful predictor of health-related events.
Figures
Similar articles
-
Sarcopenia-related parameters and incident disability in older persons: results from the "invecchiare in Chianti" study.J Gerontol A Biol Sci Med Sci. 2015 Apr;70(4):457-63. doi: 10.1093/gerona/glu181. Epub 2014 Oct 15. J Gerontol A Biol Sci Med Sci. 2015. PMID: 25320055 Free PMC article.
-
Longitudinal associations between body composition, sarcopenic obesity and outcomes of frailty, disability, institutionalisation and mortality in community-dwelling older men: The Concord Health and Ageing in Men Project.Age Ageing. 2017 May 1;46(3):413-420. doi: 10.1093/ageing/afw214. Age Ageing. 2017. PMID: 27932368
-
Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.J Frailty Aging. 2017;6(1):12-17. doi: 10.14283/jfa.2016.117. J Frailty Aging. 2017. PMID: 28244552
-
Sarcopenic-obesity and cardiovascular disease risk in the elderly.J Nutr Health Aging. 2009 May;13(5):460-6. doi: 10.1007/s12603-009-0084-z. J Nutr Health Aging. 2009. PMID: 19390754
-
Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age--An overview.Exp Gerontol. 2016 Apr;76:25-32. doi: 10.1016/j.exger.2016.01.008. Epub 2016 Jan 16. Exp Gerontol. 2016. PMID: 26785313 Review.
Cited by
-
Greater Skeletal Muscle Fat Infiltration Is Associated With Higher All-Cause and Cardiovascular Mortality in Older Men.J Gerontol A Biol Sci Med Sci. 2015 Sep;70(9):1133-40. doi: 10.1093/gerona/glv027. Epub 2015 Apr 2. J Gerontol A Biol Sci Med Sci. 2015. PMID: 25838547 Free PMC article.
-
Effect of Skeletal Muscle and Fat Mass on Muscle Strength in the Elderly.Healthcare (Basel). 2018 Jun 26;6(3):72. doi: 10.3390/healthcare6030072. Healthcare (Basel). 2018. PMID: 29949913 Free PMC article.
-
Health Consequences of Sarcopenic Obesity: A Narrative Review.Front Endocrinol (Lausanne). 2020 May 21;11:332. doi: 10.3389/fendo.2020.00332. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 32508753 Free PMC article. Review.
-
The Predictive Value of the EWGSOP Definition of Sarcopenia: Results From the InCHIANTI Study.J Gerontol A Biol Sci Med Sci. 2016 Feb;71(2):259-64. doi: 10.1093/gerona/glv129. Epub 2015 Sep 2. J Gerontol A Biol Sci Med Sci. 2016. PMID: 26333772 Free PMC article.
-
Influencing factors for the decline of limb muscle strength and the association with all-cause mortality: evidence from a nationwide population-based cohort study.Aging Clin Exp Res. 2022 Feb;34(2):399-407. doi: 10.1007/s40520-021-01940-w. Epub 2021 Jul 27. Aging Clin Exp Res. 2022. PMID: 34313962
References
-
- Morley JE, Baumgartner RN, Roubenoff R, Mayer J, Nair KS. Sarcopenia. J Lab Clin Med. 2001;137:231–243. - PubMed
-
- Baumgartner RN. Body composition in healthy aging. Ann N Y Acad Sci. 2000;904:437–448. - PubMed
-
- Marcell TJ. Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci. 2003;58A:911–916. - PubMed
-
- Iannuzzi-Sucich M, Prestwood KM, Kenny AM. Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women. J Gerontol A Biol Sci Med Sci. 2002;57:M772–M777. - PubMed
-
- Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc. 2002;50:889–896. - PubMed